SVB Leerink Initiates Coverage on Immunocore (NASDAQ:IMCR)

Stock analysts at SVB Leerink started coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a research report issued on Monday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $74.00 price target on the stock. SVB Leerink’s target price indicates a potential upside of 25.25% from the company’s current price. […]

Leave a Reply

Your email address will not be published.

Previous post Macatawa Bank (NASDAQ:MCBC) Stock Rating Upgraded by Keefe, Bruyette & Woods
Next post Geron (NASDAQ:GERN) Now Covered by TD Cowen